tiprankstipranks
Advertisement
Advertisement
STOK Earnings this Week: How Will it Perform?
PremiumPre-EarningsSTOK Earnings this Week: How Will it Perform?
1M ago
Stoke Therapeutics, Biogen publish data from zorevunersen studies in NEJM
Premium
The Fly
Stoke Therapeutics, Biogen publish data from zorevunersen studies in NEJM
1M ago
Nanogen appoints Ruff as Chief Regulatory Affairs Officer, McSherry as SVP
Premium
The Fly
Nanogen appoints Ruff as Chief Regulatory Affairs Officer, McSherry as SVP
1M ago
Stoke Therapeutics Expands with New Long-Term Waltham Headquarters
PremiumCompany AnnouncementsStoke Therapeutics Expands with New Long-Term Waltham Headquarters
2M ago
Stoke Therapeutics price target raised to $36 from $32 at Wedbush
Premium
The Fly
Stoke Therapeutics price target raised to $36 from $32 at Wedbush
3M ago
Stoke Therapeutics Accelerates Phase 3 Dravet Study Timeline
Premium
Company Announcements
Stoke Therapeutics Accelerates Phase 3 Dravet Study Timeline
3M ago
Biogen, Stoke Therapeutics announce data presentations for zorevunersen
PremiumThe FlyBiogen, Stoke Therapeutics announce data presentations for zorevunersen
4M ago
Stoke, Biogen present zorevunersen data at American Epilepsy Society
Premium
The Fly
Stoke, Biogen present zorevunersen data at American Epilepsy Society
4M ago
Biogen, Stoke Therapeutics announce publication of data from BUTTERFLY study
Premium
The Fly
Biogen, Stoke Therapeutics announce publication of data from BUTTERFLY study
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100